Jonathan Buck is a Senior Director of Oncology Global Value & Access Strategy at Gilead Sciences, leading global strategy efforts for Hematology and early oncology pipelines. They bring over 10 years of expertise in oncology biopharma market access, having previously held various roles at Genentech, including interim leadership in pricing and market access. Jonathan also held positions at companies like Monitor Group, Buck Associates, and Taproot Foundation, demonstrating a consistent track record of collaborative strategy development. They earned multiple degrees from Cornell University, including a Master of Engineering in Financial Engineering.
This person is not in the org chart
This person is not in any teams
This person is not in any offices